[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2025 World Targeted Cancer Drugs Market Research Report (by Product Type, End-User/Application and Regions/Countries)

December 2019 | 104 pages | ID: 21F6212CC83CEN
HeyReport

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Targeted Cancer Drugs , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Targeted Cancer Drugs market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc)
  • South America (Brazil, Argentina etc)
  • Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
  • Cancer Growth Blocker Drug
  • Monoclonal Antibody
  • Other
By End-User / Application
  • Hospitals
  • Academic & Research Institutes
  • Diagnostic & Reference Laboratories
By Company
  • Pfizer
  • Incyte
  • Novartis
  • Eli Lilly
  • Gilead
  • Sanofi
  • Galapagos
  • AbbVie
  • Vertex
  • Teva
  • Astellas Pharma
  • Celgene
1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use / Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use / Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS

12.THERMO FISHER SCIENTIFIC PFIZER

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Incyte
12.3 Novartis
12.4 Eli Lilly
12.5 Gilead
12.6 Sanofi
12.7 Galapagos
12.8 AbbVie
12.9 Vertex
12.10 Teva
12.11 Astellas Pharma
12.12 Celgene

13 PRICE OVERVIEW

13.1 Price Segment
13.2 Price Trend

14 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Targeted Cancer Drugs Market and Growth by Type
Table Global Targeted Cancer Drugs Market and Growth by End-Use / Application
Table Global Targeted Cancer Drugs Revenue (Million USD) by Vendors (2017-2019)
Table Global Targeted Cancer Drugs Revenue Share by Vendors (2017-2019)
Table Global Targeted Cancer Drugs Market Volume (Volume) by Vendors (2017-2019)
Table Global Targeted Cancer Drugs Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Targeted Cancer Drugs Market (Million USD) by Type (2017-2019)
Table Global Targeted Cancer Drugs Market Share by Type (2017-2019)
Table Global Targeted Cancer Drugs Market Volume (Volume) by Type (2017-2019)
Table Global Targeted Cancer Drugs Market Volume Share by Type (2017-2019)
Table Global Targeted Cancer Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Global Targeted Cancer Drugs Market Share by End-Use / Application (2017-2019)
Table Global Targeted Cancer Drugs Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Targeted Cancer Drugs Market Volume Share by End-Use / Application (2017-2019)
Table Global Targeted Cancer Drugs Market (Million USD) by Regions (2017-2019)
Table Global Targeted Cancer Drugs Market Share by Regions (2017-2019)
Table Global Targeted Cancer Drugs Market Volume (Volume) by Regions (2017-2019)
Table Global Targeted Cancer Drugs Market Volume Share by Regions (2017-2019)
Table North America Targeted Cancer Drugs Market (Million USD) by Type (2017-2019)
Table North America Targeted Cancer Drugs Market Share by Type (2017-2019)
Table North America Targeted Cancer Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table North America Targeted Cancer Drugs Market Share by End-Use / Application (2017-2019)
Table North America Targeted Cancer Drugs Market (Million USD) by Regions (2017-2019)
Table North America Targeted Cancer Drugs Market Share by Regions (2017-2019)
Table Europe Targeted Cancer Drugs Market (Million USD) by Type (2017-2019)
Table Europe Targeted Cancer Drugs Market Share by Type (2017-2019)
Table Europe Targeted Cancer Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Targeted Cancer Drugs Market Share by End-Use / Application (2017-2019)
Table Europe Targeted Cancer Drugs Market (Million USD) by Regions (2017-2019)
Table Europe Targeted Cancer Drugs Market Share by Regions (2017-2019)
Table Asia-Pacific Targeted Cancer Drugs Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Targeted Cancer Drugs Market Share by Type (2017-2019)
Table Asia-Pacific Targeted Cancer Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Targeted Cancer Drugs Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Targeted Cancer Drugs Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Targeted Cancer Drugs Market Share by Regions (2017-2019)
Table South America Targeted Cancer Drugs Market (Million USD) by Type (2017-2019)
Table South America Targeted Cancer Drugs Market Share by Type (2017-2019)
Table South America Targeted Cancer Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table South America Targeted Cancer Drugs Market Share by End-Use / Application (2017-2019)
Table South America Targeted Cancer Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market Share by Regions (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market Share by Type (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Targeted Cancer Drugs Market Share by Regions (2017-2019)
Table Global Targeted Cancer Drugs Market (Million USD) Forecast by Regions (2020-2025)
Table Global Targeted Cancer Drugs Market Share Forecast by Regions (2020-2025)
Table Global Targeted Cancer Drugs Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Targeted Cancer Drugs Market Volume Share Forecast by Regions (2020-2025)
Table Global Targeted Cancer Drugs Market (Million USD) Forecast by Type (2020-2025)
Table Global Targeted Cancer DrugsMarket Share by Forecast Type (2020-2025)
Table Global Targeted Cancer Drugs Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Targeted Cancer Drugs Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Incyte
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of Gilead
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Galapagos
Table Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Table Sales Revenue, Volume, Price, Cost and Margin of Vertex
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene

LIST OF FIGURES

Figure Global Targeted Cancer Drugs Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Targeted Cancer Drugs Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Targeted Cancer Drugs Market Volume (Volume) and Growth Forecast (2020-2025)


More Publications